CATS has been the subject of a number of other research reports. Zacks Investment Research downgraded shares of Catasys from a buy rating to a hold rating in a research report on Wednesday, November 6th. ValuEngine cut Catasys from a buy rating to a hold rating in a research report on Tuesday, December 3rd. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $18.20.
NASDAQ:CATS opened at $17.36 on Thursday. The company has a 50 day moving average price of $14.85 and a 200-day moving average price of $16.52. Catasys has a 1-year low of $8.71 and a 1-year high of $20.83. The firm has a market cap of $286.10 million, a price-to-earnings ratio of -19.51 and a beta of 1.66.
Several hedge funds have recently made changes to their positions in CATS. CIBC Private Wealth Group LLC grew its stake in Catasys by 5.2% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 16,100 shares of the company’s stock valued at $254,000 after acquiring an additional 800 shares during the period. State Street Corp lifted its holdings in Catasys by 4.5% during the third quarter. State Street Corp now owns 112,652 shares of the company’s stock valued at $1,775,000 after purchasing an additional 4,809 shares in the last quarter. Russell Investments Group Ltd. purchased a new position in Catasys during the third quarter valued at $111,000. Wells Fargo & Company MN lifted its holdings in Catasys by 257.7% during the second quarter. Wells Fargo & Company MN now owns 13,773 shares of the company’s stock valued at $264,000 after purchasing an additional 9,923 shares in the last quarter. Finally, Eagle Asset Management Inc. acquired a new stake in shares of Catasys in the second quarter valued at about $269,000. 19.54% of the stock is owned by institutional investors and hedge funds.
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Further Reading: Trade Deficit
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.